Tiktaalik Resurfaces

In today’s New York Times, science writer John Noble Wilford reports on new findings (to be published tomorrow in the journal Nature) about Tiktaalik roseae, a fossil fish that...

In today’s New York Times, science writer John Noble Wilford reports on new findings (to be published tomorrow in the journal Nature) about Tiktaalik roseae, a fossil fish that is providing “striking evidence of the intermediate steps by which some marine vertebrates evolved into animals that walked on land.” Paleontologist Neil Shubin, Ph.D. ’87, of the University of Chicago, led the expedition that found several partial skeletons of the fish in 2004.

Read the Times article here. Read more about Tiktaalik, and Shubin and his recent book, Your Inner Fish, in this magazine’s article “Fishing for Answers.”

Related topics

You might also like

From Jellyfish to Digital Hearts

How Harvard researchers are helping to build a virtual model of the human heart

Creepy Crawlies and Sticky Murder Weapons at Harvard

In the shadows of Singapore’s forests, an ancient predator lies in wait—the velvet worm.

Five Questions with Andrew Knoll

A paleontologist on how to understand Earth’s biggest extinction event

Most popular

The Life of a Harvard Spy

Richard Skeffington Welch’s illustrious—and clandestine—career in the CIA

Summers Takes Leave Amid Harvard Probe

Previously undisclosed Epstein links to Harvard affiliates leads to a University review.

What Trump Means for John Roberts’s Legacy

Executive power is on the docket at the Supreme Court.

Explore More From Current Issue

Aisha Muharrar with shoulder-length hair, wearing a green blazer and white shirt.

Parks and Rec Comedy Writer Aisha Muharrar Gets Serious about Grief

With Loved One, the Harvard grad and Lampoon veteran makes her debut as a novelist.

Professor David Liu smiles while sitting at a desk with colorful lanterns and a figurine in the background.

This Harvard Scientist Is Changing the Future of Genetic Diseases

David Liu has pioneered breakthroughs in gene editing, creating new therapies that may lead to cures.